TPO and myeloproliferative disorder: To further explore the origin of fibroblasts, genetic fate-mapping studies have been carried out and have identified LeptinR+ MSCs [166] in the TPO overexpression model of MPN as targets of inflammatory signaling that transdifferentiate into myofibroblasts.